VivoSim Labs, Inc
Organovo is a pioneering company in 3D bioprinting technology, focused on delivering scientific and medical breakthroughs through the creation of functional, three-dimensional human tissues for use in medical research, drug discovery, and therapeutic applications. The company collaborates with pharmaceutical, cosmetic, and academic partners to develop 3D human disease models, aiming to accelerate drug development and enable treatments to be developed faster and at lower cost. Organovo's innovative tissue models have been featured in major media outlets and have received numerous awards, including recognition as one of the Top 10 Most Innovative Companies in Healthcare in 2015 by Fast Company.
Industries
Nr. of Employees
medium (51-250)
VivoSim Labs, Inc
San Diego, California, United States, North America
Products
3D human liver tissue product for preclinical toxicology
A manufactured, multicellular 3D human liver tissue intended for preclinical toxicology and ADME testing, exhibiting production of liver proteins and inducible drug-metabolizing enzyme activity.
3D human kidney proximal tubule tissue product
A 3D proximal tubule tissue model created in standard plate formats, composed of epithelial, endothelial and interstitial cells for nephrotoxicity assessment and transporter function evaluation.
3D printed skin tissue product for product evaluation
Bioprinted multilayer skin tissue intended for in vitro evaluation of product safety and performance in cosmetic and research contexts.
3D human liver tissue product for preclinical toxicology
A manufactured, multicellular 3D human liver tissue intended for preclinical toxicology and ADME testing, exhibiting production of liver proteins and inducible drug-metabolizing enzyme activity.
3D human kidney proximal tubule tissue product
A 3D proximal tubule tissue model created in standard plate formats, composed of epithelial, endothelial and interstitial cells for nephrotoxicity assessment and transporter function evaluation.
3D printed skin tissue product for product evaluation
Bioprinted multilayer skin tissue intended for in vitro evaluation of product safety and performance in cosmetic and research contexts.
Services
Preclinical safety testing using 3D human tissue constructs
Contract research services that apply 3D human liver, kidney and skin tissue models to assess compound toxicity, ADME-related endpoints and disease-relevant responses for pharmaceutical and biotech customers.
Collaborative development projects
Partnership-based development with academic institutions, pharmaceutical companies and consumer-industry partners to translate 3D tissue technology into applied research and product evaluation workflows.
Preclinical safety testing using 3D human tissue constructs
Contract research services that apply 3D human liver, kidney and skin tissue models to assess compound toxicity, ADME-related endpoints and disease-relevant responses for pharmaceutical and biotech customers.
Collaborative development projects
Partnership-based development with academic institutions, pharmaceutical companies and consumer-industry partners to translate 3D tissue technology into applied research and product evaluation workflows.
Expertise Areas
- 3D bioprinting and tissue engineering
- Preclinical safety and toxicology testing
- In vitro disease modeling (liver, kidney)
- Regenerative medicine and implantable tissue development
Key Technologies
- 3D bioprinting platforms
- Multicellular biofabrication
- In vitro liver microtissues
- In vitro kidney proximal tubule models